Literature DB >> 17353087

LH/hCG action and development of ovarian cancer--a short review on biological and clinical/epidemiological aspects.

Masaki Mandai1, Ikuo Konishi, Hideki Kuroda, Shingo Fujii.   

Abstract

A link between infertility therapy, especially ovulation induction therapy using gonadotropins, and the development of ovarian cancer has long been an issue of debate since an epidemiological report supporting the possibility appeared in 1992. A number of clinical/epidemiological and biological studies, including a few that we conducted, have revealed various facts regarding this issue. The aim of this short review was to summarize the last 10 years findings and to address the implications of the debates on this issue.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17353087     DOI： 10.1016/j.mce.2006.11.014

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN： 0303-7207            Impact factor:   4.102


  11 in total

Review 1.  The luteinizing hormone receptor: insights into structure-function relationships and hormone-receptor-mediated changes in gene expression in ovarian cancer cells.

Authors:  David Puett; Krassimira Angelova; Marcelo Rocha da Costa; Susanne W Warrenfeltz; Francesca Fanelli
Journal:  Mol Cell Endocrinol       Date:  2010-05-02       Impact factor: 4.102

2.  Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.

Authors:  Ivana Rizzuto; Renee F Behrens; Lesley A Smith
Journal:  Cochrane Database Syst Rev       Date:  2019-06-18

Review 3.  Use of fertility medications and cancer risk: a review and update.

Authors:  Lindsay Kroener; Daniel Dumesic; Zain Al-Safi
Journal:  Curr Opin Obstet Gynecol       Date:  2017-08       Impact factor: 1.927

4.  CGB activates ERK and AKT kinases in cancer cells via LHCGR-independent mechanism.

Authors:  Aleksandra Głodek; Anna Jankowska
Journal:  Tumour Biol       Date:  2014-02-20

5.  Gonadotropin-regulated lymphangiogenesis in ovarian cancer is mediated by LEDGF-induced expression of VEGF-C.

Authors:  Stav Sapoznik; Batya Cohen; Yael Tzuman; Gila Meir; Shifra Ben-Dor; Alon Harmelin; Michal Neeman
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

6.  Activation of the PKC pathway stimulates ovarian cancer cell proliferation, migration, and expression of MMP7 and MMP10.

Authors:  Linah F Al-Alem; Lauren A McCord; R Chase Southard; Michael W Kilgore; Thomas E Curry
Journal:  Biol Reprod       Date:  2013-09-27       Impact factor: 4.285

Review 7.  Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.

Authors:  Ivana Rizzuto; Renee F Behrens; Lesley A Smith
Journal:  Cochrane Database Syst Rev       Date:  2013-08-13

8.  Regulation of gene expression in ovarian cancer cells by luteinizing hormone receptor expression and activation.

Authors:  Juan Cui; Brooke M Miner; Joanna B Eldredge; Susanne W Warrenfeltz; Phuongan Dam; Ying Xu; David Puett
Journal:  BMC Cancer       Date:  2011-06-28       Impact factor: 4.430

9.  Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer.

Authors:  Miriam Lenhard; Alexandra Tsvilina; Lan Schumacher; Markus Kupka; Nina Ditsch; Doris Mayr; Klaus Friese; Udo Jeschke
Journal:  BMC Cancer       Date:  2012-01-03       Impact factor: 4.430

10.  Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival.

Authors:  Miriam Lenhard; Lennerová Tereza; Sabine Heublein; Nina Ditsch; Isabelle Himsl; Doris Mayr; Klaus Friese; Udo Jeschke
Journal:  BMC Cancer       Date:  2012-11-24       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.